Aktive Positionen von Naomi Cretcher
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BIOMEA FUSION, INC. | Personalreferent | 01.02.2021 | - |
| Geschäftsführer | 01.07.2020 | 01.02.2021 |
Karriereverlauf von Naomi Cretcher
Ehemalige bekannte Positionen von Naomi Cretcher
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Chief Operating Officer | 1 |
| Human Resources Officer | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOMEA FUSION, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Kartos Therapeutics, Inc.
Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Health Technology |
- Börse
- Insiders
- Naomi Cretcher
- Erfahrung
